ARIELLE ROUNDS: Open Payments
NPI 1396372280 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,543 in 156 payments from 15 companies in 2025. Trend: 2023 $2,818 · 2024 $3,208 · 2025 $3,543
Food & beverage: $3,543
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 24 | $591 |
| ABBVIE INC. | 20 | $514 |
| Otsuka America Pharmaceutical, Inc. | 21 | $432 |
| Collegium Pharmaceutical, Inc. | 14 | $323 |
| Alkermes, Inc. | 12 | $295 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $294 |
| Axsome Therapeutics, Inc. | 11 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $227 |
| Janssen Pharmaceuticals, Inc | 6 | $171 |
| Neurocrine BioSciences, Inc. | 4 | $124 |
Products named: FANAPT, VRAYLAR, REXULTI, Jornay PM, CAPLYTA, Auvelity, TRINTELLIX, SPRAVATO.
Industry payments across RI — which companies pay providers there.
